These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11361589)

  • 21. Viramune cleared for use in combination with protease inhibitors.
    AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046
    [No Abstract]   [Full Text] [Related]  

  • 22. NDA submitted for TMC125.
    AIDS Patient Care STDS; 2007 Sep; 21(9):704. PubMed ID: 17939212
    [No Abstract]   [Full Text] [Related]  

  • 23. An overview of the drug approval process.
    Martinez LJ
    Res Initiat Treat Action; 2002; 8(1):11-7. PubMed ID: 12489521
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract]   [Full Text] [Related]  

  • 25. Sustiva granted full FDA approval.
    AIDS Read; 2000 Mar; 10(3):147. PubMed ID: 10798886
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV drug now approved for use with protease inhibitors.
    Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335
    [No Abstract]   [Full Text] [Related]  

  • 27. Transmission. Company halts Truvada PrEP for women study.
    AIDS Policy Law; 2011 Jun; 26(7):1. PubMed ID: 21735622
    [No Abstract]   [Full Text] [Related]  

  • 28. A guide to using this guide.
    Berry J
    Posit Aware; 2011; 23(2):19. PubMed ID: 21796850
    [No Abstract]   [Full Text] [Related]  

  • 29. Ziagen (abacavir) approved: caution essential.
    James JS
    AIDS Treat News; 1999 Jan; (No 310):1, 3-6. PubMed ID: 11366148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenofovir ready for approval.
    AIDS Patient Care STDS; 2001 Jul; 15(7):399. PubMed ID: 11483167
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental drug quickly suppresses HIV.
    AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15844233
    [No Abstract]   [Full Text] [Related]  

  • 32. 3TC receives full approval.
    Grodeck B; Vazquez E
    Posit Aware; 1997; 8(3):11. PubMed ID: 11364417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New medicines in development for AIDS: 1995 survey from the Pharmaceutical Research and Manufacturers of America.
    Pediatr AIDS HIV Infect; 1996 Apr; 7(2):120-1. PubMed ID: 11361480
    [No Abstract]   [Full Text] [Related]  

  • 34. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract]   [Full Text] [Related]  

  • 35. Monitoring anti-HIV medicines: what is the FDA's role?
    Mirken B
    BETA; 2001; 14(1):8-11. PubMed ID: 11695333
    [No Abstract]   [Full Text] [Related]  

  • 36. T-20 (Fuzeon) gets priority review.
    AIDS Treat News; 2002 Oct; (384):4-5. PubMed ID: 12434762
    [No Abstract]   [Full Text] [Related]  

  • 37. On approval.
    Huff B
    GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
    [No Abstract]   [Full Text] [Related]  

  • 38. Viread gets FDA nod.
    Rodriquez E
    Posit Living; 2001 Dec-2002 Jan; 10(7):33. PubMed ID: 11808509
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA approves Viread for HIV-1 infection.
    FDA Consum; 2002; 36(1):5. PubMed ID: 11881601
    [No Abstract]   [Full Text] [Related]  

  • 40. New medicines in development for AIDS. 1996 survey from the Pharmaceutical Research and Manufacturers of America.
    Pediatr AIDS HIV Infect; 1997 Feb; 8(1):67-78. PubMed ID: 11361511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.